0001231919-26-000232.txt : 20260303 0001231919-26-000232.hdr.sgml : 20260303 20260303165338 ACCESSION NUMBER: 0001231919-26-000232 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260303 DATE AS OF CHANGE: 20260303 EFFECTIVENESS DATE: 20260303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aegle Therapeutics Corp CENTRAL INDEX KEY: 0001797825 ORGANIZATION NAME: EIN: 462045726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-575311 FILM NUMBER: 26715768 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE, SUITE 160, #152 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 954-736-6682 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE, SUITE 160, #152 CITY: MIAMI STATE: FL ZIP: 33136 D 1 primary_doc.xml X0708 D LIVE 0001797825 Aegle Therapeutics Corp 400 TradeCenter Drive Suite 5900 Woburn MA MASSACHUSETTS 01801 781-918-8449 DELAWARE None None Corporation true Shelley Hartman c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Executive Officer Director David Schimel c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Leon Moulder c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Scott Braunstein c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Steve O'Hara c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Evangelos Badiavas c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Mikio Tanji c/o Aegle Therapeutics Corporation 400 TradeCenter Drive, Suite 5900 Woburn MA MASSACHUSETTS 01801 Director Biotechnology Decline to Disclose 06b false 2025-12-30 false true false 0 700000 455695 244305 false 10 0 0 0 false Aegle Therapeutics Corp /s/ Shelley Hartman Shelley Hartman Chief Executive Officer 2026-03-03